 - Subject has received more than one prior anti-tumor regimen for Stage IIIIV disease. Regimen refers to single drug or planned combination of two or more anti-tumor therapies. Bevacizumab Avastin as part of a planned sequence of therapy after first-line platinum-containing double regimen is not considered a second regimen. Neo-adjuvant treatment for resectable subjects is not considered a second regimen. 